Theranexus
Developing drug combinations that consist of one compound that targets neurons and another that modulates the activity of astrocytes.
Market cap
$22.5m
Enterprise value
$25m
Share price
€2.40 ALTHX.PA
Company register number
791889777
Authorizing premium user...